Ibutamoren (MK-677) 10mg/tab 60 Tablets by Master Pharma

Usage

1. Obtain a pre-cycle lab panel: covering IGF-1, fasting glucose, HbA1c, full lipid panel, and liver enzymes (AST, ALT, GGT) before the first tablet.
2. Begin at 10 mg daily: , taken with the evening meal to leverage the natural nocturnal GH window while food blunts any appetite response.
3. Record subjective and objective markers weekly: — body weight, sleep quality, and any oedema — to contextualise the mid-cycle bloodwork.
4. Schedule a week-four venous draw: ; review IGF-1 and fasting glucose against baseline before deciding whether to increase to 20 mg.
5. After the final tablet, observe a four-week washout: before the post-cycle draw; do not initiate a repeat protocol until IGF-1 and glucose values have returned to pre-cycle range.
6. File the Master Pharma Certificate of Analysis: alongside your lab results; matching the batch number to the analytical data completes the documentation chain for the cycle.

Warnings

Frequently asked questions

Which blood tests should I run before starting an MK-677 cycle?

Run a full pre-cycle panel covering fasting glucose, HbA1c, IGF-1, complete lipid panel, and liver enzymes (AST, ALT, GGT). These values establish your personal baseline. Because MK-677 can modestly reduce insulin sensitivity in predisposed individuals, fasting glucose and HbA1c are non-negotiable starting points — not optional extras.

How much can IGF-1 rise during an MK-677 cycle and how do I monitor it safely?

Published case series report IGF-1 increases of roughly 30–60 % above baseline at 25 mg/day. At the 10–20 mg/day range used by most researchers, rises are proportionally smaller. Schedule a venous draw at week four and compare against your pre-cycle result; if IGF-1 exceeds the upper laboratory reference limit, reduce dose before the next draw.

Does MK-677 affect liver enzymes, and should I monitor AST and ALT while using it?

MK-677 alone shows minimal hepatotoxic signal in available data; meaningful AST/ALT elevation on an MK-677-inclusive cycle typically originates from co-administered androgenic SARMs rather than from ibutamoren itself. Monitoring both analytes still matters as a safety baseline, and any elevation above 3× the upper reference limit warrants cycle suspension regardless of perceived cause.

Why is the 10 mg tablet the most useful format for a monitored protocol?

The 10 mg unit is the smallest commercially available dose increment for MK-677, allowing researchers to escalate in 10 mg steps that align with scheduled lab draws. Dose changes can be made between the baseline draw, the week-four mid-cycle draw, and the post-cycle draw without needing to split tablets or estimate partial doses.

How should Master Pharma Ibutamoren 10 mg tablets be stored after the bottle is opened?

Store tablets at room temperature (15–25 °C), away from direct light and moisture. Once the bottle is opened, reseal tightly after each use; silica gel desiccant inside the packaging helps maintain tablet integrity. Do not refrigerate — condensation cycles can degrade the tablet matrix. Use within the period stated on the batch Certificate of Analysis. (2) angle_used

Manufacturer

Master Pharma's certification framework for its oral tablet range is governed by two independently enforced standards: EU GMP compliance at the manufacturing site, and SKU-level analytical release through HPLC and LAL testing — neither standard waived for volume SKUs, neither applied selectively to premium lines. For the Ibutamoren 10 mg/tab product specifically, GMP site compliance means that environmental controls, equipment qualification records, and in-process checks are auditable at the batch level, not merely attested at brand level. The Certificate of Analysis accompanying each dispatched lot records HPLC active-content result and LAL endotoxin figure against the batch number; the receiving party can cross-reference both data points to the label before the first tablet enters any protocol.